Repurposing Therapeutics for COVID-19: Rapid Prediction of Commercially available drugs through Machine Learning and Docking

Sovesh Mahapatra; Prathul Nath; Manisha Chatterjee; Neeladrisingha Das; Deepjyoti Kalita; Partha Roy; Soumitra Satapathi

Rapid development of computer aided technology like ML based on Artificial Intelligence (AI) can help accelerate the drug development process for different diseases [18] [19] [20] . The advantage of AI approaches like ML is that they can be applied to learn from examples and build predictive models even when our understanding of the underlying biological processes is limited, or when computational simulations based on fundamental physical models are too expensive to be carried away. Another advantage of ML is to automatically learn to identify complex patterns that categorize sets from input All rights reserved. No reuse allowed without permission. the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.